Fluorescence in situ hybridization for detecting ErbB-2 amplification in breast tumor fine needle aspiration biopsies

Acta Cytologica

Volumn 40, Issue 2, 1996, Pages 164-173

  Sauter, Guido ^a,b,c   Feichter, Georg ^a,b   Torhorst, Joachim ^a,b   Moch, Holger ^a,b,c   Novotna, Hedvika ^a,b   Wagner, Urs ^a,b,d   Dürmüller, Ursula ^a,b   Waldman, Frederic M ^a,b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Aspiration biopsy; Breast neoplasms; Erbb 2 genes; Fluorescence; In situ hybridization

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029878915     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333683     Document Type: Article

References (27)

1. Borg A, Baldetorp B, Ferno M, Killander D, Olsson H, Sig-urdsson H: ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene 1991;6:137-143
2. Cajulis R, Frias-Hidvegi D: Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase nuclei with chromosome specific probes. Acta Cytol 1993;37: 391-396
3. De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D, Press O: Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res 1992;52:1916-1923
4. Gnant M, Blijham G, Reiner A, Schemper M, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R: Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer: 10 Year result. Ann Oncol 1993;4:643-650
5. Guerin M, Gabillot M, Mathieu MC, Travagli JP, Spielmann M, Andrieu N, Riou G: Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and noninflammatory breast cancer: Prognostic significance. Int J Cancer 1989;43:201-208
6. Gullick WJ, Love SB, Wright C, Barnes DM, Gusterson B, Harris AL, Altman DG: c-erbB-2 Protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer 1991;63:434-438
7. Gusterson B, Gelber R, Goldhirsch A, Price K, SaveSoderburg J, Anbazhagan R, Styles J, Rudenstam C, Golough R, Reed R, Martinez-Tollo F, Tiltman A, Torhorst J, Grigola-to P, Bettelheim R, Neville A, Burki K, Castiglione M, Collins J, Lindtner J, Senn H, Group ftI(BCS):Prognostic importance of c-erbB-2 in breast cancer. J Clin Oncol 1992;10:1049-1056
8. Hopman A, Poddighe P, Smeets A, Moesker O, Beck J, Vooijs G, Ramaekers F: Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 1990;135:1105-1117
9. Hopman A, Ramaekers F, Raap A, Beck I, Devilee P, van der Ploeg M, Vooijs G: In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 1988;89:307-316
10. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F: Trisomy 7 in nonneoplastic cells. Genes Chrom Cancer 1993;6:199-205
11. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821
12. Kallioniemi O, Kallioniemi A, Kurisu W, Thor A, Chen L, Smith H, Waldman F, Pinkel D, Gray J: C-erbB-2 oncogene amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1992;89:5321-5325
13. Langer P, Waldrop A, Ward D: Enzymatic synthesis of biotin-labeled polynucleotides: Novel nucleic acid affinity probes. Proc Natl Acad Sci USA 1981;78:6633-6637
14. Linares G, Rigaut J, Vassy J, De Olivera T, De Cremoux P, Olofsson B, Calvo F: Reflectance in situ hybridization (RISH): Detection, by confocal reflectance laser microscopy, of gold labeled riboprobes in breast cancer cell lines and histological specimens. J Microsc 1994;173:27-38
15. Matsumara K, Kallioniemi O, Kallioniemi A, Chen L, Smith H, Pinkel D, Gray J, Waldman F: Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 1992;52:3474-3477
16. Moch H, Sauter G, Moore D, Mihatsch M, Gudat F, Wald-man F: p53 and erbB-2 protein overexpression are early stage alterations in transitional cell carcinoma of the bladder. Virchows Arch A 1993;423:329-334
17. Muss H, Thor A, Berry D, Kute T, Liu E, Koerner F, Cirrin-gione C, Budmn D, Wood W, Barcos M, Henderson I: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-1266
18. Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME, King CR: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: Prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol 1990;8:103-112
19. Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, et al: Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 1991;51:556-567
20. Sauter G, Haley J, Kerschmann R, Moore D, Narayan P, Carroll P, Moch H, Gudat F, Mihatsch M, Mayall B, Waldman F: Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer (in press)
21. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch M, Gudat F, Waldman F: Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 1993; 53:2199-2203
22. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of theHER-2/neu oncogene. Science 1987;235:177-182
23. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yoko-ta J: Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 1989;49:3104-3108
24. Venter DJ, Tuzi NL, Kumar S, Gullick WJ: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Im-munohistological assessment correlates with gene amplification. Lancet 1987;2:69-72
25. Von Hoff D, McGill J, Forseth B, Davidson K, Bradley T, Van Devanter D, Wahl G: Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. Proc Natl Acad Sci USA 1992;89:8165-8169
26. Winstanley J, Cooke T, Murray GD, Platt HA, George WD, Holt S, Myskov M, Spedding A, Barraclough BR, Rudland PS: The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer 1991;63:447-450
27. Zhou DJ, Ahuja H, Cline MJ: Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 Amplification does not correlate with recurrence of disease. Oncogene 1989;4:105-108